Beyond the Label: Ensuring That Drug Benefits Outweigh Risks in the Food and Drug Administration's Risk Evaluation and Mitigation Strategy Program.

Epstein, Michael S

Beyond the Label: Ensuring That Drug Benefits Outweigh Risks in the Food and Drug Administration's Risk Evaluation and Mitigation Strategy Program. [electronic resource] - The American journal of gastroenterology 07 2019 - 1017-1019 p. digital

Publication Type: Journal Article

1572-0241

10.14309/ajg.0000000000000215 doi


Consumer Product Safety
Drug Approval--methods
Drug Labeling
Humans
Program Evaluation
Risk Evaluation and Mitigation--organization & administration
Safety Management
United States
United States Food and Drug Administration--standards